BLX-883 is a form of alfa interferon developed by Biolex for the treatment of hepatitis viral C. Alfa interferon is used in the treatment of hepatitis C, hepatitis B, and multiple cancers and its worldwide sales currently exceed $3 billion.

Synonyms: BLX-883

This is just here as a test because I lose it

Term information

database cross reference
  • PubChem Substance:347910305
hasDbXref

PubChem Substance:347910305

inScheme

https://identifiers.org/drugbank

label

BLX-883

Term relations

Subclass of: